Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 8 | 2023 | 132 | 3.440 |
Why?
|
| Lung Neoplasms | 13 | 2023 | 642 | 2.820 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 5 | 2023 | 49 | 1.860 |
Why?
|
| Cannabis | 3 | 2023 | 147 | 1.850 |
Why?
|
| Climate Change | 2 | 2021 | 27 | 1.500 |
Why?
|
| Biopsy, Fine-Needle | 5 | 2021 | 116 | 1.480 |
Why?
|
| Ticlopidine | 3 | 2016 | 57 | 1.440 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2016 | 180 | 1.310 |
Why?
|
| Marijuana Smoking | 2 | 2023 | 71 | 1.300 |
Why?
|
| Endosonography | 4 | 2023 | 96 | 1.180 |
Why?
|
| Bronchoscopes | 3 | 2023 | 11 | 1.180 |
Why?
|
| Bronchoscopy | 5 | 2019 | 79 | 1.160 |
Why?
|
| Dyspnea | 6 | 2015 | 78 | 1.150 |
Why?
|
| Lung | 6 | 2023 | 507 | 1.140 |
Why?
|
| Tracheostomy | 2 | 2020 | 81 | 1.130 |
Why?
|
| Lymph Nodes | 3 | 2017 | 284 | 1.060 |
Why?
|
| Pleural Effusion | 4 | 2019 | 38 | 1.030 |
Why?
|
| Insufflation | 1 | 2023 | 9 | 0.900 |
Why?
|
| Ultrasonography, Interventional | 2 | 2015 | 146 | 0.890 |
Why?
|
| Humans | 49 | 2023 | 54284 | 0.890 |
Why?
|
| Auscultation | 2 | 2015 | 10 | 0.860 |
Why?
|
| Cannabinoids | 1 | 2022 | 108 | 0.780 |
Why?
|
| Lung Injury | 1 | 2020 | 25 | 0.720 |
Why?
|
| Respiratory Tract Diseases | 1 | 2020 | 29 | 0.720 |
Why?
|
| Heart Failure | 2 | 2016 | 541 | 0.720 |
Why?
|
| Oxygen | 1 | 2023 | 361 | 0.710 |
Why?
|
| Air Pollution | 1 | 2020 | 45 | 0.710 |
Why?
|
| Male | 31 | 2020 | 27334 | 0.690 |
Why?
|
| Pleural Diseases | 2 | 2016 | 14 | 0.680 |
Why?
|
| Pulmonary Medicine | 2 | 2015 | 15 | 0.680 |
Why?
|
| Smoking Cessation | 3 | 2020 | 316 | 0.670 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2019 | 58 | 0.660 |
Why?
|
| Middle Aged | 23 | 2020 | 13088 | 0.650 |
Why?
|
| Asthma | 3 | 2013 | 293 | 0.630 |
Why?
|
| Hemorrhage | 2 | 2016 | 208 | 0.610 |
Why?
|
| Female | 26 | 2020 | 28441 | 0.580 |
Why?
|
| Tracheal Neoplasms | 1 | 2016 | 9 | 0.580 |
Why?
|
| Granular Cell Tumor | 1 | 2016 | 7 | 0.570 |
Why?
|
| Pandemics | 1 | 2021 | 579 | 0.540 |
Why?
|
| Cytodiagnosis | 1 | 2015 | 44 | 0.540 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 20 | 0.540 |
Why?
|
| Respiratory Sounds | 2 | 2015 | 54 | 0.530 |
Why?
|
| Esophagus | 2 | 2016 | 79 | 0.530 |
Why?
|
| Arteriovenous Fistula | 1 | 2015 | 26 | 0.520 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 22 | 0.520 |
Why?
|
| Adrenal Glands | 1 | 2014 | 37 | 0.510 |
Why?
|
| Angiography | 1 | 2015 | 147 | 0.510 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 113 | 0.480 |
Why?
|
| Retrospective Studies | 9 | 2023 | 6432 | 0.460 |
Why?
|
| Algorithms | 2 | 2015 | 697 | 0.460 |
Why?
|
| Coitus | 1 | 2013 | 20 | 0.460 |
Why?
|
| Aged | 14 | 2020 | 10054 | 0.460 |
Why?
|
| Blood Loss, Surgical | 1 | 2013 | 79 | 0.450 |
Why?
|
| Lung Diseases | 1 | 2014 | 86 | 0.450 |
Why?
|
| Thoracostomy | 1 | 2012 | 12 | 0.450 |
Why?
|
| Mediastinal Diseases | 1 | 2012 | 7 | 0.440 |
Why?
|
| Chest Tubes | 1 | 2012 | 22 | 0.440 |
Why?
|
| Preoperative Care | 1 | 2013 | 184 | 0.420 |
Why?
|
| Cricoid Cartilage | 1 | 2012 | 9 | 0.420 |
Why?
|
| Respiration, Artificial | 3 | 2023 | 285 | 0.420 |
Why?
|
| Adult | 13 | 2023 | 14207 | 0.410 |
Why?
|
| Thoracic Diseases | 1 | 2011 | 9 | 0.410 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 51 | 0.410 |
Why?
|
| Stress, Psychological | 1 | 2013 | 270 | 0.390 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2019 | 384 | 0.390 |
Why?
|
| Intubation, Intratracheal | 1 | 2012 | 130 | 0.380 |
Why?
|
| Kidney | 1 | 2015 | 820 | 0.360 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2008 | 27 | 0.340 |
Why?
|
| Cough | 2 | 2017 | 55 | 0.320 |
Why?
|
| Quality of Life | 3 | 2020 | 922 | 0.310 |
Why?
|
| Prostheses and Implants | 2 | 2019 | 61 | 0.310 |
Why?
|
| Disease Progression | 3 | 2022 | 913 | 0.310 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2007 | 6 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2017 | 1213 | 0.300 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 184 | 0.300 |
Why?
|
| Prospective Studies | 5 | 2019 | 2604 | 0.290 |
Why?
|
| Adenocarcinoma | 3 | 2017 | 428 | 0.280 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 3431 | 0.270 |
Why?
|
| Pilot Projects | 4 | 2020 | 808 | 0.270 |
Why?
|
| Chronic Disease | 2 | 2023 | 614 | 0.260 |
Why?
|
| Postoperative Complications | 1 | 2012 | 1033 | 0.250 |
Why?
|
| Risk Assessment | 2 | 2020 | 1361 | 0.230 |
Why?
|
| Receptors, Cannabinoid | 1 | 2022 | 20 | 0.220 |
Why?
|
| Pleural Effusion, Malignant | 2 | 2015 | 23 | 0.220 |
Why?
|
| Ultrasonography | 2 | 2016 | 480 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 164 | 0.210 |
Why?
|
| Analgesics | 1 | 2022 | 106 | 0.200 |
Why?
|
| Smoking | 2 | 2017 | 556 | 0.200 |
Why?
|
| Swine | 1 | 2023 | 431 | 0.200 |
Why?
|
| Airway Resistance | 2 | 2014 | 22 | 0.200 |
Why?
|
| Device Approval | 1 | 2020 | 5 | 0.190 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 806 | 0.180 |
Why?
|
| Thoracoscopy | 2 | 2019 | 20 | 0.180 |
Why?
|
| Hemoptysis | 1 | 2019 | 6 | 0.170 |
Why?
|
| Manometry | 1 | 2019 | 19 | 0.170 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 25 | 0.170 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 27 | 0.170 |
Why?
|
| Pressure | 1 | 2019 | 120 | 0.170 |
Why?
|
| Home Care Services | 1 | 2020 | 79 | 0.170 |
Why?
|
| Exercise Therapy | 1 | 2020 | 123 | 0.160 |
Why?
|
| Respiratory Function Tests | 2 | 2020 | 98 | 0.160 |
Why?
|
| Adolescent | 3 | 2015 | 6897 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 74 | 0.160 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2017 | 13 | 0.160 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 216 | 0.150 |
Why?
|
| Inflammation | 1 | 2022 | 674 | 0.150 |
Why?
|
| Gender Identity | 1 | 2017 | 26 | 0.150 |
Why?
|
| Bronchial Fistula | 1 | 2016 | 5 | 0.150 |
Why?
|
| Aging | 1 | 2023 | 784 | 0.150 |
Why?
|
| Critical Illness | 1 | 2020 | 344 | 0.150 |
Why?
|
| Mediastinum | 1 | 2016 | 27 | 0.150 |
Why?
|
| Referral and Consultation | 1 | 2019 | 307 | 0.150 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 1048 | 0.150 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 14 | 0.140 |
Why?
|
| United States | 2 | 2020 | 5217 | 0.140 |
Why?
|
| Prevalence | 2 | 2017 | 1025 | 0.140 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 47 | 0.140 |
Why?
|
| Metabolome | 1 | 2017 | 109 | 0.140 |
Why?
|
| Prognosis | 3 | 2020 | 2118 | 0.140 |
Why?
|
| Airway Obstruction | 1 | 2016 | 51 | 0.140 |
Why?
|
| Gambling | 1 | 2015 | 19 | 0.140 |
Why?
|
| Exercise Test | 2 | 2020 | 151 | 0.140 |
Why?
|
| Air Pollution, Indoor | 1 | 2015 | 28 | 0.140 |
Why?
|
| Pleurodesis | 1 | 2015 | 8 | 0.130 |
Why?
|
| Laser Therapy | 1 | 2016 | 91 | 0.130 |
Why?
|
| Particulate Matter | 1 | 2015 | 56 | 0.130 |
Why?
|
| Pleura | 1 | 2015 | 15 | 0.130 |
Why?
|
| Cost Savings | 1 | 2015 | 67 | 0.130 |
Why?
|
| Epidemics | 1 | 2015 | 19 | 0.130 |
Why?
|
| Environmental Monitoring | 1 | 2015 | 71 | 0.130 |
Why?
|
| Treatment Outcome | 3 | 2016 | 5604 | 0.130 |
Why?
|
| Pneumothorax | 1 | 2015 | 21 | 0.130 |
Why?
|
| Esophageal Neoplasms | 2 | 2019 | 100 | 0.130 |
Why?
|
| Physical Exertion | 1 | 2015 | 67 | 0.130 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2015 | 56 | 0.130 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 131 | 0.130 |
Why?
|
| Foot | 1 | 2015 | 50 | 0.130 |
Why?
|
| Comorbidity | 1 | 2017 | 663 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 295 | 0.130 |
Why?
|
| Arginine | 1 | 2016 | 182 | 0.130 |
Why?
|
| Edema | 1 | 2015 | 74 | 0.120 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 291 | 0.120 |
Why?
|
| Sex Factors | 1 | 2017 | 767 | 0.120 |
Why?
|
| Erythrocyte Indices | 1 | 2013 | 8 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2016 | 298 | 0.120 |
Why?
|
| Dilatation | 1 | 2013 | 27 | 0.120 |
Why?
|
| Addison Disease | 1 | 2013 | 3 | 0.120 |
Why?
|
| Hyperkalemia | 1 | 2013 | 11 | 0.120 |
Why?
|
| Hyponatremia | 1 | 2013 | 15 | 0.120 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 367 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 923 | 0.110 |
Why?
|
| Age Factors | 1 | 2016 | 1198 | 0.110 |
Why?
|
| Patient Safety | 1 | 2013 | 121 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 501 | 0.110 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 258 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1089 | 0.110 |
Why?
|
| Hypotension | 1 | 2013 | 67 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2013 | 1228 | 0.110 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 69 | 0.110 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2011 | 9 | 0.100 |
Why?
|
| Pneumonia | 2 | 2017 | 129 | 0.100 |
Why?
|
| Necrosis | 1 | 2012 | 208 | 0.100 |
Why?
|
| Fatigue | 1 | 2012 | 129 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2012 | 154 | 0.100 |
Why?
|
| Blood Gas Analysis | 1 | 2011 | 32 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2015 | 1543 | 0.100 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 127 | 0.100 |
Why?
|
| Neoplasms | 1 | 2021 | 1316 | 0.100 |
Why?
|
| Intensive Care Units | 1 | 2012 | 231 | 0.100 |
Why?
|
| Radiography | 1 | 2012 | 524 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1476 | 0.090 |
Why?
|
| Palliative Care | 1 | 2012 | 188 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1084 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2387 | 0.090 |
Why?
|
| Sound Spectrography | 1 | 2008 | 9 | 0.090 |
Why?
|
| Vibration | 1 | 2008 | 14 | 0.090 |
Why?
|
| Pain | 1 | 2012 | 405 | 0.080 |
Why?
|
| Risk Factors | 2 | 2016 | 3935 | 0.080 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2007 | 2 | 0.080 |
Why?
|
| Methacholine Chloride | 1 | 2007 | 4 | 0.080 |
Why?
|
| Animals | 1 | 2023 | 14385 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2007 | 95 | 0.070 |
Why?
|
| Bronchodilator Agents | 1 | 2007 | 74 | 0.070 |
Why?
|
| Young Adult | 1 | 2015 | 4318 | 0.070 |
Why?
|
| Arkansas | 2 | 2020 | 2100 | 0.050 |
Why?
|
| Anthropometry | 1 | 2020 | 96 | 0.040 |
Why?
|
| Lost to Follow-Up | 1 | 2019 | 11 | 0.040 |
Why?
|
| Oncology Service, Hospital | 1 | 2019 | 14 | 0.040 |
Why?
|
| Science | 1 | 2017 | 17 | 0.040 |
Why?
|
| Kynurenine | 1 | 2017 | 17 | 0.040 |
Why?
|
| Glutathione Disulfide | 1 | 2017 | 45 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2017 | 46 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2017 | 48 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 692 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 195 | 0.040 |
Why?
|
| Fever | 1 | 2017 | 129 | 0.040 |
Why?
|
| Public Facilities | 1 | 2015 | 4 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 113 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 327 | 0.030 |
Why?
|
| Talc | 1 | 2015 | 7 | 0.030 |
Why?
|
| Citrulline | 1 | 2016 | 98 | 0.030 |
Why?
|
| Professional Role | 1 | 2016 | 88 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 322 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2016 | 262 | 0.030 |
Why?
|
| Spirometry | 1 | 2015 | 30 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2015 | 68 | 0.030 |
Why?
|
| Drainage | 1 | 2015 | 79 | 0.030 |
Why?
|
| Self Care | 1 | 2016 | 147 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 96 | 0.030 |
Why?
|
| Syndrome | 1 | 2015 | 252 | 0.030 |
Why?
|
| Amino Acids | 1 | 2016 | 369 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2016 | 242 | 0.030 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2013 | 7 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2013 | 43 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2016 | 353 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 692 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 3213 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 683 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1136 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 2008 | 15 | 0.020 |
Why?
|
| Inhalation | 1 | 2008 | 6 | 0.020 |
Why?
|
| Exhalation | 1 | 2008 | 19 | 0.020 |
Why?
|